medigraphic.com

2001, Number 4

<< Back Next >>

Rev Mex Anest 2001; 24 (4)

Farmacología y uso clínico de la levobupivacaína. Un nuevo anestésico local

Velázquez SR, Plancarte SR

Language: Spanish
References: 52
Page:
PDF size: 76.12 Kb.


Text Extraction




REFERENCES

  1. Mc Caughey, Mirakhur RK. Drugs in anaesthetic practice and analgesia. In: Speight TM, Holford NGH, ed. Avery´s drug treatment. 4th ed. Auckland: Adis International. 1997; 451-467.

  2. Burm AGL, Van Der Meer AD, Van Kleef JW, et al. Pharmacokinetics of the enantiomers of bupivacaína following intravenous administration of the racemate. Br J Clin Pharmacol 1994; 38:125-129.

  3. Tucker GT, Lennard MS. Enantiomers specific pharmacokinetics. Pharmacol Therap 1990; 54:309-320.

  4. Bardsley H, Gristwood R, Barker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clinical Pharmacol 1998; 46:245-249.

  5. Bader AM, Tsen LC, Camann WR, et al. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999; 90; 6:1596-1601.

  6. Mather LE, Huang YF, Veering B, et al. Systemic and regional pharmacokinetics of levobupivacaine and bupivacaine enantiomers in sheep. Anesth. Analg. 1998; 86:805-811.

  7. Fernández L, Simonetti MPB. Vascular effects of S (-) bupivacaine RS (+) bupivacaine and ropivacaine on isolated strips of human umbilical vein: preliminary results. Reg Anesth 1997; 22 Suppl:65.

  8. Gristwood RW, Greaves JL. Levobupivacaine: a new safer long acting local anaesthetic agent. Expert Opin Invest Drug 1999; 8:861-876.

  9. McGlade D, Kalpokas M, Money P, et al. Comparison of 0.5% ropivacaína and 0.5% bupivacaína in lumbar epidural anesthesia for lower limb orthopedic surgery. Anesth Intensive Care 1997; 25:262-266.

  10. Mather L. levobupivacaine: a view point. Drugs 1998; 56:363-386.

  11. Kanai Y, Tateyama, Nakamura T, et al. Effects of levobupivacaine, bupivacaine, and ropivacaine on tail-flick response and motor function in rats following epidural or intrathecal administration. Reg Anesth Pain Med 1999; 24:444-452.

  12. Dyhre H, Lang M, Wallin R, et al. The duration of action of bupivacaine, levobupivacaine, ropivacaine and pethidine in peripheral nerve block in rat. Acta Anaesthesiol Scand 1997; 41:1346-1352.

  13. Morrison SG, Dominguez JJ, Frascarolo P et al. Cardiotoxic effects of levobupivacaine, bupivacaine and ropivacaine. Reg Anesth Pain Med 1998; 23:3 suppl:50.

  14. Valenzuela C, Snyder DJ, Bennett PB, et al. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation 1995; 92:3014-3024.

  15. Stuart GM. A comparison of the electrocardiographic cardiotoxic effects of racemica bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine. Anesth Analg 2000; 90:1308-1314.

  16. Kopacz DJ, Allen HW. Accidental intravenous levobupivacaine. Anesth & Analg 1999; 89:1027-1031.

  17. Huang YP, Prior ME, Mather LC, et al. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998; 86:797-804.

  18. Valenzuela C, Delpon E, Tamkun MM, et al. Stereoselective block of a human cardiac potassium channel by bupivacaine enantiomers. Biophys J 1995; 69:418-427.

  19. Heath ML. Deaths after intravenous regional anaesthesia. BMJ 1982; 2, 285:913-916.

  20. Graf BM, Martín E, Bosnjak ZJ, et al. Stereospecific effect of bupivacaine isomers on atrioventricular conduction in the isolated perfused guinea pig Herat. Anesthesiology 1997; 86:410-419.

  21. McDonald SB, Liu SS, Kopacz DJ et al. Hyperbaric spinal ropivacaine. A comparison to bupivacaine in volunteers. Anesthesiology 1990; 4: 971-977.

  22. Harding DP, Collier PA, Huckle RM, et al. Cardiotoxic effects of levobupivacaine, bupivacaine and ropivacaine: an in vitro study in guinea pigs and human cardiac muscle. Br J Pharmacol 1998; 125 suppl:127.

  23. Mazoit JX, Decaux J, Bouazis H, et al. Comparative effect of racemica bupivacaine, levobupivacaine and ropivacaine on isolated rabbit heart. Anesthesiology 1999; 91-3A:A885.

  24. Mitchell ME. Local anesthetic toxic effects. In Atlee JL (eds): Complications in Anesthesia. Philadelphia, WB Saunders 1999: 249-253.

  25. Reynolds F. Adverse effects of local anaesthetics. Br J Anaesth 1987; 59:78-95.

  26. Scott DJ. Toxic effects of local anesthetic agents on the centra nervous system. Br J Anaesth 1986; 58:732-735.

  27. Hogan Q. Local anesthetic toxicity: An update. Reg Anesth 1996; 21:43-50.

  28. Denson DD, Behbehani MM, Gregg RV. Enantiomer specific effects of an intravenously administered arrythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992; 17:311-316.

  29. Van F, Rolan PE, Venian N, et al. Differential effects of levo and racemic bupivacaine on the EEG in volunteers. Reg Anesth Pain Med 1998; 23 suppl:48.

  30. Robinson APC, Lyons GR, Wilson RC, et al. Levobupivacaine for extradural analgesia in labour; the sparing effect of extradural fentanyl. Br J Anaesth 1999; 82 suppl1:208.

  31. Santos AC, Karpel B, Noble G, et al. The placental transfer and fetal effects of levobupivacaine, racemic bupivacaine and ropivacaine. Anesthesiology 1999; 90:1698-1703.

  32. Cox CR, Faccenda KA, Gilhooly C, et al. Extradural S (-)-bupivacaine: comparison with racemica RS bupivacaine. Br J Anaesth 1998; 80:289-293.

  33. Burke D, Henderson DJ, Simpson AM. Comparison of 0.25% S (-)-bupivacaine with 0.25% RS-bupivacaine for epidural analgesia in labour. Br j Anaesth 1999; 83:750-755.

  34. Gunter JB, Greeg T, Varagherse AM, et al. Levobupivacaine for ilioinguinal/iliohypogastric nerve block in children. Anesth Analg 1999; 89:647-649.

  35. Purdue Pharma L.P. Chirocaine (levobupivacaine injection) prescribing information. Norwalk, USA, 1999.

  36. Abbott laboratories. Chirocaine 2.5 mg/ml; summary of product characteristics. Cambridge UK, 1999.

  37. Foster RH, Markham. Levobupivacaine: A review of its pharmacology and uses as a local anaesthetic. Drugs 2000, 59; 3:551-579.

  38. British National Formulary. No 38. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1999.

  39. Kopacz DJ, Allen HW, Thompson GE. A comparison of epidural levobupivacaine 0.75% with racemica bupivacaine for lower abdominal surgery. Anesth Analg 2000; 90:642-648.

  40. Cox CR, Checkett MR, Mackenzie N, et al. Comparison of S (-)-bupivacaine with racemica (RS)-bupivacaine in supraclavicular brachial plexus block. Br j Anaesth 1998; 80:594-598.

  41. Bay-Nielsen, Klarskov B, Bech K, et al. Levobupivacaine vs bupivacaine as infiltration anaesthesia in inguinal herniorrhaphy. Br. J Anaesth 1999; 82:280-282.

  42. Curvey P, Burke D, Donaldson L, et al. Comparison of 0.125% levobupivacaine and 0.125% bupivacaine epidural infusions for labor analgesia. Br J Anaesth 1999; 82 Suppl 1:163.

  43. Convery P, Milligan KR, Weir P, et al. The efficacy and safety of epidural infusions of levobupivacaine with and without clonidina for post-operative pain relief in patients undergoing total hip replacement. Anesthesiology 1998; 89 supple 3A:850.

  44. Crews JC, Hord AH, Denson DD, et al. A comparison of the analgesic efficacy of the 0.25% levobupivacaine combined with 0.005% morphine, 0.25% levobupivacaine alone, or 0.005% morphine alone for the management of postoperative pain in patients undergoing mayor abdominal surgery. Anesth Analg 1999; 89:150-159.

  45. Kopacz DJ, Sharrock NE, Allen HW. A comparison of levobupivacaine 0.125%, fentanyl 4mg.ml, or their combination for patient-controlled epidural analgesia after mayor orthopedic surgery. Anesth Analg 1999; 89:1497-1503.

  46. Milligan KR, Convery PN, Weir P, et al. The efficacy and safety of epidural infusions of levobupivacaína with and without clonidine for postoperative pain relief in patients undergoing total hip replacement. Anesth & Analg 2000; 91:393-397.

  47. Robinson PA, Lyons GR, Wilson RC, et al. Levobupivacaine for epidural analgesia in labor: The sparing effect of epidural fentanil. Anesth & Analg 92: 410-414.

  48. Crews JC, Foreman AS, Weller RS, et al. Onset, duration and dose tolerability of levobupivacaine 0.5% for axillary brachial plexus neural blockade. Anesthesiology 1998; 83A Suppl:A894.

  49. Thomas JM, Schung SA. Recent advances in the pharmacokinetics of local anaesthetics: long acting amide enantiomers and continuous infusions. Clin Pharmacokinet 1999; 36:67-83.

  50. Burke D. MacKenzie M, Newton D, et al. A comparison of vasoactivity between levobupivacaína and bupivacaína. Int Monitor 1998; 10:66-68.

  51. Kopacz DJ, Helman JD, Nussbaum CE, et al. A comparison of epidural levobupivacaine 0.5% with or without epinephrine for lumbar spine surgery. Anesth & Analg 2001; 93:755-760.

  52. Bradsley H, Gristwood R, Watson N, et al. The local anaesthetic activity of levobupivacaine does not differ from racemica bupivacaine (marcain): first clinical evidence. Expert Opin Invest Drug 1997; 6:1883-1885.




2020     |     www.medigraphic.com